Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VCs Cite Early Planning As Key To Big Paydays On Device Startups

This article was originally published in The Gray Sheet

Executive Summary

Enteric Medical and Spinal Dynamics Corp. (SDC) exemplify venture capital-backed firms sold to large medical device players for healthy returns on investment dollars, according to panelists at the Wilson Sonsini Goodrich & Rosati medical device meeting in San Jose, Calif. June 18-19

You may also be interested in...



Medtronic’s $270 Mil. SDC Artificial Disc Purchase Supplements Internal R&D

Medtronic will continue its in-house artificial disc R&D program following the acquisition of Bryan cervical disc system developer Spinal Dynamics Corp. (SDC) as part of a two-pronged strategy to develop an alternative to spinal fusion devices for degenerative disc disease

Investors Go Berserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel